Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Pharmacology Studies: Comparison Across Research Models

Achilles tendon transection (rat) Tensile strength restoration at 14 days 78% vs 31% VEGF/FGF upregulation, collagen organization 10 mcg/kg daily Strongest evidence for tendon healing acceleration Ethanol-induced gastric ulcer (rat) Lesion area reduction 60–80

This comparison does not assign a generated winner or score.

  • Achilles tendon transection (rat)
  • Tensile strength restoration at 14 days
  • 78% vs 31%
  • VEGF/FGF upregulation, collagen organization
  • 10 mcg/kg daily
  • Strongest evidence for tendon healing acceleration
  • Ethanol-induced gastric ulcer (rat)
  • Lesion area reduction
  • 60–80% reduction
  • Increased mucosal blood flow, HSP70 upregulation
  • 10–100 mcg/kg
  • Consistent cytoprotective effect across ulcer models
  • Ischemia-reperfusion injury (rat femoral artery ligation)
  • Blood flow restoration to ischemic limb
  • 40–55% improvement
  • Angiogenesis via VEGFR-2, NO modulation
  • Evidence for collateral vessel formation
  • IBD analog (TNBS-induced colitis, rat)
  • Histological damage score, inflammatory markers
  • 50–65% reduction in damage score
  • TNF-α and IL-6 downregulation, mucosal barrier stabilization
  • Promising for gut barrier integrity studies
  • Myocardial injury (isoproterenol-induced, rat)
  • Infarct size, ejection fraction
  • 30–40% infarct size reduction
  • Cardioprotective via anti-apoptotic signaling, preserved mitochondrial function
  • 10 mcg/kg pre-treatment
  • Limited studies; mechanism less defined than musculoskeletal effects
More references

Related material